We are live on ! Find out more
SRTA icon

Strata Critical Medical

127 hedge funds and large institutions have $181M invested in Strata Critical Medical in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 46 increasing their positions, 29 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more capital inflows, than outflows

Capital inflows: $16.6M | Capital outflows: $8.76M

59% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 29

50% more first-time investments, than exits

New positions opened: 30 | Existing positions closed: 20

8% more funds holding

Funds holding: 118 → 127 (+9)

2.1% more ownership

Funds ownership: 53.33% → 55.43% (+2.1%)

66% less call options, than puts

Call options by funds: $1.51M | Put options by funds: $4.48M

Holders
127
Holders Change
+9
Holders Change %
+7.63%
% of All Funds
1.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
46
Reduced
29
Closed
20
Calls
$1.51M
Puts
$4.48M
Net Calls
-$2.96M
Net Calls Change
-$3.02M

SRTA Hedge Fund Activity: Q2 2025 in Review

127 of the 7,631 institutional investors tracked by Wall St. Rank reported a position in Strata Critical Medical (SRTA) for Q2 2025, worth a combined $181M — up 55% from $117M a quarter earlier.

Buyers outnumbered sellers: 30 funds opened new SRTA positions and 20 closed out — a net gain of 10 holders — while 46 added to existing stakes and 29 trimmed.

The largest buyer was Prelude Capital Management, opening a new position worth an estimated $2.9M. The largest seller was JP Morgan Chase, cutting an estimated $1.3M.

  • 127 institutional investors held Strata Critical Medical (SRTA) as of Q2 2025, up from 118 in Q1 2025.
  • Funds reported $181M of Strata Critical Medical stock for Q2 2025, up 55% quarter-over-quarter.
  • 30 funds opened new Strata Critical Medical positions in Q2 2025 and 20 closed out, a net change of +10 holders.
  • The largest Strata Critical Medical buyer in Q2 2025 was Prelude Capital Management, an estimated $2.9M added.
  • The largest Strata Critical Medical seller in Q2 2025 was JP Morgan Chase, an estimated $1.3M sold.

Based on aggregated 13F filings for Q2 2025.